Pulmonary Allergy Drugs Advisory Committee Members

Pulmonary Allergy Drugs Advisory Committee

September 6, 2002

Holiday Inn Gaithersburg

COMMITTEE CHAIRMAN
Mark S. Dykewicz, M.D.
Professor of Internal Medicine
Director of Training Program in Allergy and Immunology
Department of Internal Medicine
Saint Louis University School of Medicine
1402 South Grand Boulevard – Doisy R-209
St. Louis, MO 63104

EXECUTIVE SECRETARY
Kimberly Littleton Topper
Advisors and Consultants Staff
Center for Drug and Evaluation and Research
Food and Drug Administration, (HFD-21)
5600 Fishers Lane
Rockville, MD 20857
(301) 827-7001 Fax: (301) 827-6776
Email: topperk@cder.fda.gov

Andrea J. Apter, M.D., MSC
Associate Professor Pulmonary,
Allergy, and Critical Care Division
829 Gates Building
Hospital of the University of Pennsylvania
Philadelphia, PA 19104

Peter E. Morris, M.D., FACP, FCCP
Assistant Professor of Medicine
Wake Forest University School of Medicine
Medical Center Boulevard
Winston-Salem, NC 27157-1054

Jesse Joad, M.D.
Professor of Pediatrics
U.C. Davis Medical Center
Department of Pediatrics
2516 Stockton Boulevard
Sacramento, CA 95817

T. Prescott Atkinson, M.D., Ph.D.
Associate Professor
Department of Pediatrics
University of Alabama, Wallace Tumor Institute
1824 6^th Avenue South Room 378
Birmingham, AL 35294-3300

Vernon Chinchilli, Ph.D.
Department of Health Evaluation Sciences, A210
Pennsylvania State University College of Medicine
600 Center View Drive Suite 2200
Hershey, PA 17033-0855

Polly E. Parsons, M.D.
Professor
Department of Medicine
Pulmonary and Critical Care Medicine
Fletcher Allen Health Center, University of Vermont
111 Colchester Avenue
Patrick Building, Room 310
Burlington, VT 05401

Jean G. Ford, M.D.
Florence Irving Assistant Professor
Harlem Hospital Center
Columbia University College of Physicians and Surgeons
Division of Pulmonary and Critical Care Medicine
506 Lenox Avenue, MLK 12-106
New York, NY 10037

Erik R. Swenson, M.D.
Division of Pulmonary and Critical Care Medicine
University of Washington. S111-Pulm. Pulmonary
VA Puget Sound Health Care System
1660 S. Colombian Way
Seattle, WA 98108

Consumer Representative
Karen Schell, RRT
2612 Lincoln Street
Emporia, KS 66801

Industry Representative
William J. Kennedy, Ph.D.
Pharmaceutical Consultant
PO Box 230
Rehoboth Beach, DE 19971

*Committee includes voting consultants as members

Consultants:

James K. Stoller, M.S., M.D.
Vice Chair
Division of Medicine, Associate Chief of Staff,
Head, Section of Respiratory Therapy
Department of Pulmonary and Critical Care Medicine
Cleveland Clinic Foundation
9500 Euclid Avenue
Cleveland, Ohio 44195

Donald Patrick, Ph.D.
University of Washington
1959 NE Pacific Street, Bldg. H-689
School of Public Health and Community Medicine
Seattle, WA 98195-7660

Guest

Michael Schatz, M.D.
Southern California Permanente Medical Group
7060 Clairemont Mesa Boulevard
San Diego, CA 92111

FDA Representatives:

Badrul Chowdhury, M.D., Ph.D.
Acting Director
Division of Pulmonary and Allergy Drug Products
HFD-570
Office of Drug Evaluation II
Office of New Drugs
Center for Drug Evaluation and Research
Food and Drug Administration
5600 Fishers Lane
Rockville, MD 20852

Eugene Sullivan, M.D.
Medical Officer
Division of Pulmonary and Allergy Drug Products
HFD-570
Office of Drug Evaluation II
Office of New Drugs
Center for Drug Evaluation and Research
Food and Drug Administration
5600 Fishers Lane
Rockville, MD 20852

Robert J. Meyer, M.D.
Director
Office of Drug Evaluation II, HFD-102
Office of New Drugs
Center for Drug Evaluation and Research
Food and Drug Administration
5600 Fishers Lane
Rockville, MD 20852

Lisa A. Kammerman, Ph.D.
Biometrics Team Leader
Division of Biometrics 2
Office of Biostatistics, HFD-715
Center for Drug Evaluation and Research
Food and Drug Administration
5600 Fishers Lane
Rockville, MD 20852